FOXP3 and cancer: Data from patients suffering from a wide range of cancer types has further indicated that there appears to be a positive correlation between increased number of intra-tumoral FoxP3-expressing CD4+ T cells and poor prognosis for cancer patients (Curiel et al., 2004).